|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan C, Lin B, Huang Z, Cui D, Zhu M, Ma Z,
Zhang Y, Liu F and Liu Y: MicroRNA-873 inhibits colorectal cancer
metastasis by targeting ELK1 and STRN4. Oncotarget. 10:4192–4204.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang Z, Li X, Liu S, Li C, Wang X and
Xing J: miR-141-3p inhibits cell proliferation, migration and
invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys
Res Commun. 514:699–705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du T and Zamore PD: Beginning to
understand microRNA function. Cell Res. 17:661–663. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V and Chen X: The regulation of
genes and genomes by small RNAs. Development. 134:1635–1641. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Voorhoeve PM: MicroRNAs: Oncogenes, tumor
suppressors or master regulators of cancer heterogeneity? Biochim
Biophys Acta. 1805:72–86. 2010.PubMed/NCBI
|
|
9
|
Cai C, Ashktorab H, Pang X, Zhao Y, Sha W,
Liu Y and Gu X: MicroRNA-211 expression promotes colorectal cancer
cell growth in vitro and in vivo by targeting tumor suppressor
CHD5. PLoS One. 7:e297502012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu
CW, Wang K, Zheng S, Ng SS, Chan FK, et al: MicroRNA-139-5p exerts
tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Mol Cancer. 13:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bertoli G, Cava C, Diceglie C, Martelli C,
Rizzo G, Piccotti F, Ottobrini L and Castiglioni I: MicroRNA-567
dysregulation contributes to carcinogenesis of breast cancer,
targeting tumor cell proliferation, and migration. Breast Cancer
Res Treat. 161:605–616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
13
|
Chen X, Ruan A, Wang X, Han W, Wang R, Lou
N, Ruan H, Qiu B, Yang H and Zhang X: miR-129-3p, as a diagnostic
and prognostic biomarker for renal cell carcinoma, attenuates cell
migration and invasion via downregulating multiple
metastasis-related genes. J Cancer Res Clin Oncol. 140:1295–1304.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB,
Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL,
Andersen CL, Zieger K, et al: Genomic profiling of microRNAs in
bladder cancer: miR-129 is associated with poor outcome and
promotes cell death in vitro. Cancer Res. 69:4851–4860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu X, Song H, Xia T, Han S, Xiao B, Luo L,
Xi Y and Guo J: Growth inhibitory effects of three miR-129 family
members on gastric cancer. Gene. 532:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karaayvaz M, Zhai H and Ju J: miR-129
promotes apoptosis and enhances chemosensitivity to 5-fluorouracil
in colorectal cancer. Cell Death Dis. 4:e6592013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poncy A, Antoniou A, Cordi S, Pierreux CE,
Jacquemin P and Lemaigre FP: Transcription factors SOX4 and SOX9
cooperatively control development of bile ducts. Dev Biol.
404:136–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jang SM, Kim JW, Kim CH, An JH, Johnson A,
Song PI, Rhee S and Choi KH: KAT5-mediated SOX4 acetylation
orchestrates chromatin remodeling during myoblast differentiation.
Cell Death Dis. 6:e18572015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andersen CL, Christensen LL, Thorsen K,
Schepeler T, Sørensen FB, Verspaget HW, Simon R, Kruhøffer M,
Aaltonen LA, Laurberg S and Ørntoft TF: Dysregulation of the
transcription factors SOX4, CBFB and SMARCC1 correlates with
outcome of colorectal cancer. Br J Cancer. 100:511–523. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang B, Li Y, Tan F and Xiao Z: Increased
expression of SOX4 is associated with colorectal cancer
progression. Tumour Biol. 37:9131–9137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vishnubalaji R, Hamam R, Yue S, Al-Obeed
O, Kassem M, Liu FF, Aldahmash A and Alajez NM: MicroRNA-320
suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Oncotarget. 7:35789–35802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu F, Min J, Cao X, Liu L, Ge Z, Hu J and
Li X: miR-363-3p inhibits the epithelial-to-mesenchymal transition
and suppresses metastasis in colorectal cancer by targeting Sox4.
Biochem Biophys Res Commun. 474:35–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao J, Xu J and Zhang R: MicroRNA-539
inhibits colorectal cancer progression by directly targeting SOX4.
Oncol Lett. 16:2693–2700. 2018.PubMed/NCBI
|
|
24
|
Zhang P, Li J, Song Y and Wang X:
miR-129-5p inhibits proliferation and invasion of chondrosarcoma
cells by regulating SOX4/Wnt/β-catenin signaling pathway. Cell
Physiol Biochem. 42:242–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang M, Li Y, Liu W, Wang R, Tang A, Hao
H, Liu Z and Ou H: miR-129-2 suppresses proliferation and migration
of esophageal carcinoma cells through downregulation of SOX4
expression. Int J Mol Med. 32:51–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong CE, Yu JS, Quigley DA, To MD, Jen KY,
Huang PY, Del Rosario R and Balmain A: Inflammation and Hras
signaling control epithelial-mesenchymal transition during skin
tumor progression. Genes Dev. 27:670–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang Z, Li X, Liu S, Li C, Wang X and
Xing J: miR-141-3p inhibits cell proliferation, migration and
invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys
Res Commun. 514:699–705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar
|
|
30
|
Yang W, Lee DY and Ben-David Y: The roles
of microRNAs in tumorigenesis and angiogenesis. Int J Physiol
Pathophysiol Pharmacol. 3:140–155. 2011.PubMed/NCBI
|
|
31
|
Jiang C, Wang H, Zhou L, Jiang T, Xu Y and
Xia L: MicroRNA-212 inhibits the metastasis of nasopharyngeal
carcinoma by targeting SOX4. Oncol Rep. 38:82–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma Y, Zhang P, Wang F, Zhang H, Yang J,
Peng J, Liu W and Qin H: miR-150 as a potential biomarker
associated with prognosis and therapeutic outcome in colorectal
cancer. Gut. 61:1447–1453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhai J, Qu S, Li X, Zhong J, Chen X, Qu Z
and Wu D: miR-129 suppresses tumor cell growth and invasion by
targeting PAK5 in hepatocellular carcinoma. Biochem Biophys Res
Commun. 464:161–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Huang JQ, Zhang X and Shen LF:
miR-129-2 functions as a tumor suppressor in glioma cells by
targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell
Biochem. 404:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, Wang H, Ke H and Ni S: miR-129
regulates MMP9 to control metastasis of non-small cell lung cancer.
Tumour Biol. 36:5785–5790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ya G, Wang H, Ma Y, Hu A, Ma Y, Hu J and
Yu Y: Serum miR-129 functions as a biomarker for colorectal cancer
by targeting estrogen receptor (ER) β. Pharmazie. 72:107–112.
2017.PubMed/NCBI
|
|
37
|
Lin J, Shi Z, Yu Z and He Z: LncRNA
HIF1A-AS2 positively affects the progression and EMT formation of
colorectal cancer through regulating miR-129-5p and DNMT3A. Biomed
Pharmacother. 98:433–439. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thomson S, Petti F, Sujka-Kwok I, Mercado
P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley
JD: A systems view of epithelial-mesenchymal transition signaling
states. Clin Exp Metastasis. 28:137–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Q, Jiang J, Fu Y, Liu T, Yu Y and
Zhang X: miR-129-5p functions as a tumor suppressor in gastric
cancer progression through targeting ADAM9. Biomed Pharmacother.
105:420–427. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Setijono SR, Park M, Kim G, Kim Y, Cho KW
and Song SJ: miR-218 and miR-129 regulate breast cancer progression
by targeting Lamins. Biochem Biophys Res Commun. 496:826–833. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jafarnejad SM, Ardekani GS, Ghaffari M,
Martinka M and Li G: Sox4 mediated dicer expression is critical for
suppression of melanoma cell invasion. Oncogene. 32:2131–2139.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ramezani-Rad P, Geng H, Hurtz C, Chan LN,
Chen Z, Jumaa H, Melnick A, Paietta E, Carroll WL, Willman CL, et
al: SOX4 enables oncogenic survival signals in acute lymphoblastic
leukemia. Blood. 121:148–155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Chen P, Zu L, Liu B, Wang M and Zhou
Q: MicroRNA-338-3p suppresses metastasis of lung cancer cells by
targeting the EMT regulator Sox4. Am J Cancer Res. 6:127–140.
2016.PubMed/NCBI
|
|
45
|
Slattery ML, Mullany LE, Sakoda L,
Samowitz WS, Wolff RK, Stevens JR and Herrick JS: The NF-κB
signalling pathway in colorectal cancer: Associations between
dysregulated gene and miRNA expression. J Cancer Res Clin Oncol.
144:269–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lan F, Yue X, Ren G, Li H, Ping L, Wang Y
and Xia T: miR-15a/16 enhances radiation sensitivity of non-small
cell lung cancer cells by targeting the TLR1/NF-κB signaling
pathway. Int J Radiat Oncol Biol Phys. 91:73–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ren D, Yang Q, Dai Y, Guo W, Du H, Song L
and Peng X: Oncogenic miR-210-3p promotes prostate cancer cell EMT
and bone metastasis via NF-κB signaling pathway. Mol Cancer.
16:1172017. View Article : Google Scholar : PubMed/NCBI
|
